Regentis Biomaterials Ltd - Company Review
Regentis Biomaterials Ltd - Company ReviewSummary
Regentis Biomaterials Ltd (Regentis Biomaterials) is a tissue repair company that develops and hydrogel platform for the repair of damaged tissue. The company’s GelrinC hydrogel implant is a cell free; off-the-shell implants is used for the treatment of injuries to articular knee cartilage and the hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen. It offers products for the repair of cartilage defects such as microfracture, mosaicplasty, osteochondral autologous transplantation system, autologous chondrocyte implantation and physical cues for regrowth of hyaline cartilage. The company utilizes biosynthetic hydrogel as platform technology to develop groundbreaking treatment for patients. It operates through its offices in the US and Israel. Regentis Biomaterials is headquartered in Or-Akiva, Israel.
This comprehensive company report of Regentis Biomaterials Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.